NEW YORK, July 10 – Sequenom of San Diego said Tuesday it had sold five MassArray systems, bringing the total number sold in the second quarter to nine.

The buyers include BioServe Biotechnologies, Centagenetix, Indiana University School of Medicine, LGC, and one undisclosed party. 

"We continue to experience an increasing demand for our MassArray product line," Toni Schuh, CEO of Sequenom, said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

The Economist writes that an increasing number of scientific journals don't do peer review.

In Science this week: genetic overlap among many psychiatric disorders, and more.